tiprankstipranks
Trending News
More News >

Rohto Pharmaceutical Sees Profit Decline Amid Sales Growth

Rohto Pharmaceutical Sees Profit Decline Amid Sales Growth

Rohto Pharmaceutical Co (JP:4527) has released an update.

Confident Investing Starts Here:

Rohto Pharmaceutical Co. reported a significant decline in profits for the first half of fiscal year 2025, with net income dropping by 22.1% compared to the previous year, despite an 8.8% rise in net sales. The company has also revised its dividend forecast, reflecting cautious optimism for the remainder of the fiscal year.

For further insights into JP:4527 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1